Management of Hepatitis C Infection
Summary
- SVR is defined as undetectable HCV RNA 24 weeks following treatment end
- For patients treated with PI-containing regimens, SVR is specifically defined as HCV RNA < 25 IU/mL at Week 24 posttreatment
- SVR at 12 weeks after completion of treatment has been adopted by drug approval bodies as a surrogate for SVR24
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Hepatitis C-Treatment